Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 27Non-metastatic Castration-resistant Prostate Cancer 2Neoplasm Metastasis 2Urogenital Neoplasms 1Prostatic Neoplasms, Castration-Resistant 1Prostatic Diseases 1Prostate Cancer Metastatic 1Non-metastatic Prostate Cancer 1Newly Diagnosed Oligometastatic Prostate Cancer 1Neoplasms by Site 1Neoplasms 1Metastatic Castration-Resistant Prostate Cancer 1Low Risk Prostate Cancer 1Genital Neoplasms, Male 1Genital Diseases, Male 1Castration Levels of Testosterone 1Advanced Prostate Carcinoma 1

Interventions

enzalutamide 1darolutamide 1apalutamide 1abiraterone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Advanced Prostate Carcinoma × apalutamide × Clear all
NCT05612880 2025-01-09

Physical Function During ARSI Treatment

UNC Lineberger Comprehensive Cancer Center

Completed
24 enrolled
Genitourinary

Advanced Prostate Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡